Agenda
Thursday, September 10, 2020 |
||
10:00 AM |
Exhibit Hall Opens |
|
10:30 AM |
RA Treatment: Evidence to Make Choices Among (Nearly) Equal Therapies |
|
11:15 AM |
Anti-Drug Antibodies and Slowing Drug Clearance: Maintiaing Efficacy of Biologics |
|
11:55 AM |
JAK Safety |
|
12:30 PM |
Predicting and Preventing RA – Is the Future Close? |
|
1:05 PM |
Question and Answer Session |
|
1:20 PM |
Break and Visit Exhibit Hall |
|
1:45 PM |
Vaccinating Patients with Rheumatic Diseases |
|
2:20 PM |
Evidence Based Choice of Initial and Second Therapies: Review the Data in PSA |
|
2:55 PM |
Opportunistic Infections in the Immunosuppressed Patient – The Specific Therapy Matters! |
|
3:30 PM |
Question and Answer Session |
|
3:45 PM |
Sessions End |
|
Friday, September 11, 2020 |
||
10:00 AM |
Exhibit Hall Opens |
|
10:30 AM |
Messages from the OA Guidelines |
|
11:05 AM |
The Powerful Placebo: As Much in the Genes as In the Head? |
|
11:40 AM |
Interventional Therapies for Knee OA: Game Changers vs Expensive Placebos? |
|
12:15 PM |
Longitudinal Management of Patients on Bisphosphonate Therapy – Determining Efficacy and Minimizing Side Effects |
|
12:50 PM |
Question and Answer Session |
|
1:05 PM |
Break and Visit Exhibit Hall |
|
1:30 PM |
Scleroderma: Recognizing and Following |
|
2:05 PM |
Checkpoint Inhibitor Related Autoimmune Disease |
|
2:55 PM |
Myositis Antibodies – When to Order and How to Use |
|
3:30 PM |
Question and Answer Session |
|
3:45 PM |
Sessions End |
|
Saturday, September 12, 2020 |
||
10:00 AM |
Exhibits Open |
|
10:30 AM |
The Diagnosis and Spectrum of Spondylarthritis |
|
11:05 AM |
Sorting Out Interstitial Lung Disease in the Patient with Rheumatic Disease |
|
11:40 AM |
Treatment of Low Bone Density in CKD |
|
12:15 PM |
2020 ACR Gout Guidelines and Paradigms |
|
12:50 PM |
Question and Answer Session |
|
1:05 PM |
Break and Visit Exhibits |
|
1:30 PM |
Highlight Messages from the ACR Vasculitis Guidelines |
|
2:05 PM |
Lupus: Positioning the New Therapies in the Clinic |
|
2:40 PM |
Recognizing Atypical HUS in the Lupus Patient |
|
3:15 PM |
Question and Answer Session |
|
3:30 PM |
Cannabinoid Therapy: Rolling Along |
|
4:05 PM |
Raynaud’s – Therapeutic Options in the Management of Severe Raynaud’s |
|
4:40 PM |
Question and Answer Session |
|
5:00 PM |
Conference Ends |
|
On DemandPrimary Care |
||
Educational Program and Events Schedule as listed above are subject to change. |
Jointly Provided By


In Association With


